In this issue:
Insulin pumps vs. injections in young patients with type 1 diabetes
Identifying hypoglycaemia-related ED/hospital use in type 2 diabetes
Monogenic diabetes in Australia
Trial vs. real-world outcomes for GLP-1 agonists and DPP-4 inhibitors
Poor adherence to metformin before starting second-line agents
Sulfonylurea pharmacology and CV/hypoglycaemic event risk
Acute kidney injury, lactate levels and lactic acidosis with metformin
UK trends in type 2 diabetes
NZ children’s exposure to food marketing
Supporting NZ initiative for ‘water-only’ schools
Please login below to download this issue (PDF)